This paper explores the economic incentives that oncologists face when deciding between oral and intravenous oncolytics and their impact on prescribing behavior.
Joseph J. Conoshenti Jr, BPharm, RPh, MBA
Advertisement
Articles by Joseph J. Conoshenti Jr, BPharm, RPh, MBA
Advertisement
Latest Updated Articles
- Practice Economics and the Decision to Prescribe Oral Oncolytics
Published: December 6th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5
